Following an abbreviated submission
tobramycin 300mg/4ml nebuliser solution (Bramitob) is accepted for use in NHS Scotland for the management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients with cystic fibrosis aged 6 years and older.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
This preparation offers an alternative to an existing nebuliser solution at a lower cost per dose.
Download detailed advice53KB (PDF)
- Medicine name:
- tobramycin (Bramitob)
- SMC ID:
- Chronic pulmonary infection
- Pharmaceutical company
- Trinity Chiesi Pharmaceuticals
- BNF chapter
- Submission type
- Date advice published:
- 09 March 2009